BPH - Benign Prostatic Enlargement - Results from #2740

Efficacy and safety of combination therapy with mirodenafil and α(1)-blocker for benign prostatic hyperplasia-induced lower urinary tract symptoms accompanied by erectile dysfunction: A multicenter, open-label, prospective study - Abstract September 2, 2011

Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: Practice patterns from the observational BPH Registry - Abstract September 1, 2011

Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia - Abstract August 31, 2011

Bipolar plasma vaporization vs monopolar and bipolar TURP-a prospective, randomized, long-term comparison - Abstract August 30, 2011

Treating benign prostatic hyperplasia with botulinum neurotoxin - Abstract August 29, 2011

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia - Abstract August 26, 2011

Performance of the American Urological Association Symptom Index with and without an additional urge incontinence item - Abstract August 23, 2011

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia - Abstract August 16, 2011

Urological aspects of the metabolic syndrome - Abstract August 16, 2011

Current benign prostatic hyperplasia treatment: Impact on sexual function and management of related sexual adverse events - Abstract August 12, 2011

TURP and sex: Patient and partner prospective 12 years follow-up study - Abstract August 10, 2011

Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: A prospective, randomized, multi-center, double-blind, placebo-controlled study - Abstract August 10, 2011

Urodynamic studies in the evaluation of the older man with lower urinary tract symptoms: When, which ones, and what to do with the results - Abstract August 8, 2011

Venous thromboembolism after surgery for benign prostatic hyperplasia - Abstract August 1, 2011

Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia - Abstract July 29, 2011

Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) - Abstract July 29, 2011

Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy - Abstract July 28, 2011

Complications and clinical outcome 18 months after bipolar and monopolar transurethral resection of the prostate - Abstract July 27, 2011

Urinary incontinence following surgery for bph: The role of aging on the incidence of bladder dysfunction - Abstract July 26, 2011

Safety and feasibility of the prostatic urethral lift: A novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) - Abstract July 26, 2011

Page 138 of 142